Triobimet 1mg/500mg/15mg Tablet ER
Marketer
Corona Remedies Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Triobimet 1mg/500mg/15mg Tablet ER
Glycotrim ER tablets (1mg/500mg/15mg) combine three medications to effectively manage blood glucose in adults with type 2 diabetes. Used alongside diet and exercise, this formulation enhances insulin utilization, resulting in improved blood sugar control. Dosage and duration should strictly adhere to your physician's instructions. Administer with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case it should be omitted. Never double the dose; overdose risks hypoglycemia (low blood sugar). Concomitant use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Pre-existing kidney, liver, or heart conditions, pregnancy, or breastfeeding require prior consultation with your doctor, who will assess kidney function before initiating treatment. Limit alcohol consumption to reduce potential side effects.
Uses of Triobimet 1mg/500mg/15mg Tablet ER
Managing Type 2 Diabetes
Major Benefits of Triobimet 1mg/500mg/15mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Triobimet 1mg/500mg/15mg Extended-Release tablet whole; do not chew, crush, or divide it. Administer this medicine with food.
Common Side effects of Triobimet 1mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Triobimet 1mg/500mg/15mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Triobimet 1mg/500mg/15mg Extended-Release tablet should be administered with a meal.
How Triobimet 1mg/500mg/15mg Tablet ER works:
Triobimet 1mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone to manage blood sugar levels. This triple-drug approach offers superior glycemic control when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Triobimet 1mg/500mg/15mg extended-release tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Extended-release Triobimet tablets (1mg/500mg/15mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Triobimet tablets (1mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Triobimet 1mg/500mg/15mg Extended-Release tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Triobimet 1mg/500mg/15mg Extended-Release tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should use Triobimet 1mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Medical advice is recommended. Triobimet 1mg/500mg/15mg Extended-Release tablets are contraindicated in individuals with severe liver disease.
What if you forget to take Triobimet 1mg/500mg/15mg Tablet ER :
Should you forget to take your Triobimet 1mg/500mg/15mg Extended-Release tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triobimet 1mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |






